Adela Mazo

991 total citations
20 papers, 810 citations indexed

About

Adela Mazo is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Adela Mazo has authored 20 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Adela Mazo's work include Virus-based gene therapy research (7 papers), Cancer Research and Treatments (6 papers) and Cancer-related Molecular Pathways (5 papers). Adela Mazo is often cited by papers focused on Virus-based gene therapy research (7 papers), Cancer Research and Treatments (6 papers) and Cancer-related Molecular Pathways (5 papers). Adela Mazo collaborates with scholars based in Spain and United States. Adela Mazo's co-authors include Gabriel Capellá, Marçal Pastor‐Anglada, F. Javier Casado, José Manuel García-Manteiga, Míriam Molina‐Arcas, Lourdes Farré, Sergio A. Guerrero, Ramón Mangues, Isolda Casanova and Manel Cascalló and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Adela Mazo

20 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adela Mazo Spain 13 520 394 138 135 108 20 810
R Silvestrini Italy 14 558 1.1× 507 1.3× 79 0.6× 252 1.9× 96 0.9× 29 969
Johanna Tuomela Finland 19 327 0.6× 537 1.4× 56 0.4× 179 1.3× 68 0.6× 49 984
Sandra Muñoz-Galván Spain 18 387 0.7× 661 1.7× 49 0.4× 215 1.6× 84 0.8× 40 1.0k
Laura Stanbery United States 17 557 1.1× 441 1.1× 70 0.5× 242 1.8× 85 0.8× 54 1.1k
Masamichi Mori Japan 17 407 0.8× 524 1.3× 141 1.0× 49 0.4× 93 0.9× 41 1.1k
Robert Kubiak Poland 18 206 0.4× 553 1.4× 127 0.9× 196 1.5× 55 0.5× 77 1.1k
Jonathan F. Anker United States 14 519 1.0× 617 1.6× 56 0.4× 251 1.9× 74 0.7× 31 1.1k
Lunxi Liang China 10 457 0.9× 503 1.3× 44 0.3× 267 2.0× 88 0.8× 16 1.0k
Quanhong Sun United States 16 264 0.5× 599 1.5× 91 0.7× 164 1.2× 57 0.5× 28 936
Lukas Baitsch Switzerland 13 935 1.8× 385 1.0× 66 0.5× 108 0.8× 62 0.6× 13 1.5k

Countries citing papers authored by Adela Mazo

Since Specialization
Citations

This map shows the geographic impact of Adela Mazo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adela Mazo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adela Mazo more than expected).

Fields of papers citing papers by Adela Mazo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adela Mazo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adela Mazo. The network helps show where Adela Mazo may publish in the future.

Co-authorship network of co-authors of Adela Mazo

This figure shows the co-authorship network connecting the top 25 collaborators of Adela Mazo. A scholar is included among the top collaborators of Adela Mazo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adela Mazo. Adela Mazo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pérez‐Torras, Sandra, Juan José Lozano, Marta R. Romero, et al.. (2016). Pharmacogenomic analyzis of the responsiveness of gastrointestinal tumor cell lines to drug therapy: A transportome approach. Pharmacological Research. 113(Pt A). 364–375. 4 indexed citations
2.
Pérez‐Torras, Sandra, et al.. (2015). Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors. BMC Cancer. 15(1). 223–223. 17 indexed citations
3.
Mato-Berciano, Ana, et al.. (2013). uPAR-controlled oncolytic adenoviruses eliminate cancer stem cells in human pancreatic tumors. Stem Cell Research. 12(1). 1–10. 11 indexed citations
4.
Pérez‐Torras, Sandra, Meritxell Carrió, Anna Cascante, et al.. (2011). Connexin-26 Is a Key Factor Mediating Gemcitabine Bystander Effect. Molecular Cancer Therapeutics. 10(3). 505–517. 30 indexed citations
5.
Pérez‐Torras, Sandra, Rosa Miquel, Vanessa Almendro, et al.. (2011). Characterization of human pancreatic orthotopic tumor xenografts suitable for drug screening. Cellular Oncology. 34(6). 511–521. 20 indexed citations
6.
Pérez‐Torras, Sandra, José Manuel García-Manteiga, Elena Mercadé, et al.. (2008). Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer. Biochemical Pharmacology. 76(3). 322–329. 40 indexed citations
7.
Huch, Meritxell, Daniel Abate‐Daga, Josep Roig, et al.. (2006). Targeting the CYP2B1/Cyclophosphamide Suicide System to Fibroblast Growth Factor Receptors Results in a Potent Antitumoral Response in Pancreatic Cancer Models. Human Gene Therapy. 17(12). 1187–1200. 11 indexed citations
8.
Cascalló, Manel, Joaquim Calbó, Gabriel Capellá, et al.. (2005). Enhancement of Gemcitabine-Induced Apoptosis by Restoration of p53 Function in Human Pancreatic Tumors. Oncology. 68(2-3). 179–189. 16 indexed citations
9.
Adán, Jaume, Roser Pagan, Francesc Mitjans, et al.. (2004). Anti-migratory and anti-angiogenic effect of p16: A novel localization at membrane ruffles and lamellipodia in endothelial cells. Angiogenesis. 7(4). 323–333. 28 indexed citations
10.
Roig, Josep, Miguel Ángel Molina‐Vila, Anna Cascante, et al.. (2004). Adenovirus-Mediated Retinoblastoma 94 Gene Transfer Induces Human Pancreatic Tumor Regression in a Mouse Xenograft Model. Clinical Cancer Research. 10(4). 1454–1462. 11 indexed citations
11.
García-Manteiga, José Manuel, Míriam Molina‐Arcas, F. Javier Casado, Adela Mazo, & Marçal Pastor‐Anglada. (2003). Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity.. PubMed. 9(13). 5000–8. 174 indexed citations
12.
Cascalló, Manel, Gabriel Capellá, Adela Mazo, & Ramón Alemany. (2003). Ras-dependent oncolysis with an adenovirus VAI mutant.. PubMed. 63(17). 5544–50. 56 indexed citations
13.
Calbó, Joaquim, Matilde Parreño, Elena Sotillo, et al.. (2002). G1 Cyclin/Cyclin-dependent Kinase-coordinated Phosphorylation of Endogenous Pocket Proteins Differentially Regulates Their Interactions with E2F4 and E2F1 and Gene Expression. Journal of Biological Chemistry. 277(52). 50263–50274. 72 indexed citations
14.
Calbó, Joaquim, Mario Marotta, Manel Cascalló, et al.. (2001). Adenovirus-mediated wt- p16 reintroduction induces cell cycle arrest or apoptosis in pancreatic cancer. Cancer Gene Therapy. 8(10). 740–750. 28 indexed citations
15.
16.
Cascalló, Manel, Joaquim Calbó, Josep Lluís Gelpí, & Adela Mazo. (2000). Modulation of drug cytotoxicity by reintroduction of wild-type p53 gene (Ad5CMV-p53) in human pancreatic cancer. Cancer Gene Therapy. 7(4). 545–556. 35 indexed citations
17.
Guerrero, Sergio A., Isolda Casanova, Lourdes Farré, et al.. (2000). K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.. PubMed. 60(23). 6750–6. 205 indexed citations
18.
Gelpí, Josep Lluís, Montserrat Busquets, Santıago Imperial, et al.. (1993). A theoretical approach to the discrimination and characterization of the different classes of reversible inhibitors. Journal of Chemical Education. 70(10). 805–805. 11 indexed citations
19.
Domenech, Carlos E., et al.. (1987). Microheterogeneity of the malate dehydrogenase from several sources. Biochemical and Biophysical Research Communications. 147(2). 753–757. 5 indexed citations
20.
Domenech, Carlos E., et al.. (1986). Malate Dehydrogenase Species in the Cytosolic Fraction of Chicken Liver. Biological Chemistry Hoppe-Seyler. 367(2). 1069–1076. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R Silvestrini Breakdown of academic impact, for papers by Johanna Tuomela Breakdown of academic impact, for papers by Sandra Muñoz-Galván Breakdown of academic impact, for papers by Laura Stanbery Breakdown of academic impact, for papers by Masamichi Mori Breakdown of academic impact, for papers by Robert Kubiak Breakdown of academic impact, for papers by Jonathan F. Anker Breakdown of academic impact, for papers by Lunxi Liang Breakdown of academic impact, for papers by Quanhong Sun Breakdown of academic impact, for papers by Lukas Baitsch
Rankless by CCL
2026